Recent advances in SCF ubiquitin ligase complex: Clinical implications
Author:
Funder
National Natural Science Foundation of China
NIH
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference207 articles.
1. Drug discovery in the ubiquitin–proteasome system;Nalepa;Nat. Rev. Drug Discov.,2006
2. Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets;Bedford;Nat. Rev. Drug Discov.,2011
3. Regulated protein turnover: snapshots of the proteasome in action;Bhattacharyya;Nat. Rev. Mol. Cell Biol.,2014
4. SCF ubiquitin ligase-targeted therapies;Skaar;Nat. Rev. Drug Discov.,2014
5. RBR E3 ubiquitin ligases: new structures, new insights, new questions;Spratt;Biochem. J.,2014
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure–activity relationship;European Journal of Medicinal Chemistry;2024-11
2. Long non-coding RNA Linc00657 up-regulates Skp2 to promote the progression of cervical cancer through lipid reprogramming and regulation of immune microenvironment;Cytokine;2024-04
3. METTL3-mediated lncRNA HOXD-AS1 stability regulates inflammation, and the migration and invasion of trophoblast cells via the miR-135a/ β-TRCP axis;Non-coding RNA Research;2024-03
4. Unraveling role of ubiquitination in drug resistance of gynecological cancer;American Journal of Cancer Research;2024
5. CYR61 Acts as an Intracellular Microtubule-Associated Protein and Coordinates Mitotic Progression via PLK1-FBW7 Pathway;International Journal of Biological Sciences;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3